Louise T Chow

Title: The Innovations of Louise T Chow

Introduction

Louise T Chow is a prominent inventor based in Mountain Brook, Alabama. He has made significant contributions to the field of biotechnology, particularly in the development of vectors for gene expression. His work has implications for medical research and therapeutic applications.

Latest Patents

Louise T Chow holds a patent titled "Human papillomavirus vectors for the episomal transduction of host cells and method of making same." This patent describes a replicon designed for the delivery of a transgene for episomal gene expression in mammalian host cells. The replicon includes a transgene with an open reading frame or other nucleic acid sequence for transcription into RNA, controlled by a first surrogate promoter. Additionally, it features a gene sequence that expresses a papillomavirus replication initiator protein E1 under the control of a second surrogate promoter. The replicon also incorporates a second gene sequence that expresses the papillomavirus replication origin binding protein E2, controlled by a third surrogate promoter. The transgene and the two sequences are integrated within at least one plasmid and fewer than three plasmids. Louise T Chow has 1 patent to his name.

Career Highlights

Louise T Chow is affiliated with the UAB Research Foundation at the University of Alabama at Birmingham. His work at this institution has allowed him to explore innovative solutions in the field of gene therapy and molecular biology. His research has the potential to advance our understanding of viral vectors and their applications in medicine.

Collaborations

Louise T Chow has collaborated with notable colleagues, including Eric J Sorscher and Nianxiang Zou. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Louise T Chow's contributions to biotechnology through his patent and research at the UAB Research Foundation highlight his role as an influential inventor. His work continues to pave the way for advancements in gene therapy and related fields.